Robert L. Myers - 23 Sep 2022 Form 4 Insider Report for Predictive Oncology Inc. (POAI)

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Bob Myers
Issuer symbol: POAI
Transactions as of: 23 Sep 2022
Net transactions value: -$4,028
Form type: 4
Filing time: 27 Sep 2022, 15:06:55 UTC
Previous filing: 20 May 2022
Next filing: 02 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	POAI	Common Stock	Options Exercise		+33,333	+85%		72,669	23 Sep 2022	Direct	F1, F2
transaction	POAI	Common Stock	Tax liability	$4,028	-10,199	-14%	$0.3949	62,470	23 Sep 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	POAI	Restricted Stock Units	Options Exercise	$0	-33,333	-50%	$0.000000	33,333	23 Sep 2022	Common Stock	33,333		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On September 23, 2020, the reporting person was granted 100,000 restricted stock units, vesting in three annual installments on each of September 23, 2021, September 23, 2022 and September 23, 2023.
F2	Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock. The shares are delivered to the Reporting Person upon vesting.
F3	10,199 shares of common stock forfeited to Company on September 23, 2022 to cover withholding tax, in accordance with Restricted Stock Unit Agreement between Reporting Person and Company.